Agoracom Blog Home

Posts Tagged ‘stocks’

« Older Entries
Newer Entries »

St-Georges $SX $SX.ca $SXOOF Provides Update on #Lithium Processing Technology Initiative & Iceland #Gold Exploration

Posted by AGORACOM-JC at 2:44 PM on Friday, April 24th, 2020
  • Secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant
  • Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed
  • These segmented R&D silos will now come together and be integrated within the pilot plant operations

Montreal – April 24, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE: 85G1) is pleased to announce that it has secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant.

Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed. These segmented R&D silos will now come together and be integrated within the pilot plant operations.

As previously announced on February 10, 2020, in the “Winter Update” press release, the Company expected to secure an agreement within the second quarter of 2020. The use of ready-made facilities will generate significant cost reductions and represent a faster alternative than the building of a pilot plant from scratch. St-Georges’ management evaluated different proposals from various potential providers that were intended to meet the Company’s requirements.

The main contractor retained tipped the balance in its favor with a wealth of experience and state-of-the-art, ready-made facilities that only required certain adjustments specific to the St-Georges process. The team expects an adjustment period, and plant trial runs during Q2 and Q3 2020, subject to Quebec COVID-19 confinement releases. Full pilot scale testing should be initiated in or around the beginning of this year Q4.

The Company is expecting to receive materials from Iconic Minerals Ltd. (TSX-V: ICM) in accordance with the next phase of the on-going research and development program in place with the Company. Discussions are being held with various mines operators and mineral developers. Producers of spodumene concentrate have shown interest in supplying material for testing.

Quebec Lithium Resources

St-Georges also sourced material from a Quebec-based lithium project. The Company’s contractors will be preparing 10 to 15 tonnes of material that should yield results of approximately three metric tonnes of industry-grade spodumene concentrate suitable for pilot testing with the St-Georges’ process. The material should be available to the metallurgical team in the weeks following the Quebec government’s lifting of the COVID-19 lock-down. Sourcing local Quebec material qualifies the Company to apply for certain governmental grants, and the Company expects to apply for these grants in 2020.

Enrico Di Cesare, President of St-Georges Metallurgy Corp., commented: “Our partners’ facilities seem built for St-Georges. Under the circumstances, it would be non-sensical to spend time and money to replicate the facilities that they own. These groups have significant experience with concentrating, acids and solutions we will be using. In addition, it de-risks St-Georges by allowing us to focus on development work that is on-going. St-Georges looks forward to working with all our partners at CTMP (Centre de Technologie Minerale et de Plasturgie inc.), which has performed the early development work and will continue to work with the St-Georges team. We feel we will be able to accelerate the development and eventual market acceptance of the products we intend to produce. We believe this combination of laboratory work at bench scale and eventual large-scale pilot plant operations will accelerate our development work. We feel blessed to have two quality partners to move forward with, and we continue our collaborations with universities that specialize in this field of work.“

St-Georges Metallurgy Corp.

On February 27, 2020, St-Georges incorporated a new subsidiary, St-Georges Metallurgy Corp., and appointed Enrico Di Cesare as its President and CEO. This entity is owned 100% by St-Georges and will handle all metallurgical R&D, laboratory partnerships, metallurgical joint ventures, and related intellectual property.

In April, the Company has secured the services of a veteran metallurgist, Mr. Ian J. Cox, to work on the projects with a focus on both lithium and nickel

Ian has a degree in fuel and combustion science, from Leeds University, UK. With post-grad courses in project management from the University of Tennessee, leadership from Harvard, and finance from the Massachusetts Institute of Technology (MIT), he is an experienced project manager/process engineer with extensive experience in new process development and transition from development to design and operation. Ian has built a profitable business in highly competitive international markets. He builds strong multi-function teams with international joint venture/partnering experience.

Iceland Exploration Update

The previously announced work programs in Iceland (See September 3 2019 Press Release), were not finished due to extreme weather conditions. With the arrival of spring and the Icelandic government allowing people to circulate for work as the COVID-19 confinement directives are being eased, the Company expects to be able to finish its Thor sampling program and send those samples to Canada for processing in May, with Vopna and Troll to follow in June-July. No resolution has yet materialized in regard to drilling the Thor property. Management expects to be able to drill this summer, but no certainty can be given in that regard.

Covid-19 Impacts Assessment

The Covid-19 pandemic impacts all of the Company’s Quebec operations. Quebec North-Shore exploration operations are halted until further notice from the government. The Company is using this period to prepare its intervention plan to meet with the First Nations on whose ancestral territory the projects lie. The current process requires 60 to 90 days to receive the relevant permits. It is currently impossible to know when this process will be initiated.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur Thor Vilhjalmsson”

Vilhjalmur Thor Vilhjalmsson

President and CEO

About St-Georges

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , ,
Posted in St Georges Eco-Mining Technologies | Comments Off on St-Georges $SX $SX.ca $SXOOF Provides Update on #Lithium Processing Technology Initiative & Iceland #Gold Exploration

Ontario to resume issuing new #cannabis store authorizations – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:03 PM on Friday, April 24th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Ontario to resume issuing new cannabis store authorizations

  • Ontario’s cannabis store regulator will resume issuing new store authorizations for stores that have met regulatory requirements, according to a notice posted to its website today.

The Alcohol and Gaming Commission of Ontario (AGCO) hit pause on new Retail Store Authorizations (RSA) in early April due to emergency measures enacted by the province to fight the COVID-19 pandemic.

New store openings in Ontario are essential to maintaining the growth of Canada’s cannabis industry.

Ontario’s five-dozen cannabis stores put the province far behind Alberta and British Columbia – the provincial leaders in marijuana retail – which have opened 181 and 446 stores, respectively.

Despite that, Ontario’s adult-use cannabis sales rose 3% in February to 38 million Canadian dollars ($27 million), leading Canada.

“Restrictions imposed by the emergency order, including the pause to construction work, have delayed many new retailers in the preparation of their stores. However, the AGCO will resume issuing RSAs to those stores that have met all regulatory requirements,” the Alcohol and Gaming Commission of Ontario said in the statement.

Applying for an Retail Operator License (ROL) is the first step for businesses seeking to open a licensed cannabis store in Ontario. It also determines that store operators meet eligibility criteria.

The next step involves Retail Store Authorization (RSA) applications, which deal with the particulars of a physical cannabis store such as location, layout and security plans.

As of early April, Ontario’s cannabis regulator received nearly 900 Retail Operator License (ROL) applications for marijuana stores since it opened up the process to all comers on Jan. 6.

Ontario previously ordered private cannabis stores to close for two weeks as of April 4 because of the coronavirus. Soon after, the stores were given at least a 14-day window to continue serving customers through curbside pickups and home delivery.

Source: https://mjbizdaily.com/ontario-to-resume-issuing-new-cannabis-store-authorizations/

Tags: , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Ontario to resume issuing new #cannabis store authorizations – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

#Mhealth Study to Test Cardiac Effects of Potential COVID-19 Treatment – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 9:35 AM on Friday, April 24th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

mHealth Study to Test Cardiac Effects of Potential COVID-19 Treatment

A French study will use a smartwatch and mHealth platform to monitor ECG data from COVID-19 patients being treated with hydroxychloroquine, a potential therapy for the Coronavirus but one that may have serious side effects.

  • An mHealth study being launched in France will use an mHealth wearable to monitor cardiac activity in COVID-19 patients being treated with hydroxychloroquine and azithromycin, a drug therapy eyes as a potential treatment for the Coronavirus.

Source: ThinkStock

By Eric Wicklund

April 22, 2020 – An mHealth study being launched in France will use an mHealth wearable to monitor cardiac activity in COVID-19 patients being treated with hydroxychloroquine and azithromycin, a drug therapy eyes as a potential treatment for the Coronavirus.

Researchers at the University Hospital of Marseille will be using a smartwatch develop by Withings and integrated with an AI-based mHealth platform developed by Boston-and-Paris-based Cardiologs. The platform is designed to remotely monitor a user’s ECG data for QT prolongation.

“A significant QT prolongation can lead to ventricular arrhythmia and potentially deadly consequences” Laurent Fiorina, a cardiologist at the Institut Cardiovasculaire Paris Sud (ICPS) and Cardiologs executive who helped launch the study, said in a press release. “It is thus important to closely monitor the QT interval during this treatment.”

“The objective of our study is to evaluate a new method for QT measurement using Cardiologs’ AI-based solution and ECG data collected via smartwatches,” added Professor Jean-Claude Deharo, head of the cardiac arrhythmia department at the University Hospital of Marseille and the principal investigator of the study. “Smartwatches are already used in the clinical setting but do not have validated QT analysis available. Combining these technologies will enable clinicians to overcome the practical limitations in the context of COVID-19 of the standard cardiac safety strategy that requires heavy patient interaction.”

Often used to prevent or treat malaria caused by mosquito bites, hydroxychloroquine has be held up by several people – including President Donald Trump – as a potential means of treating the Coronavirus. But many in the healthcare industry have pointed out the drug’s potentially dangerous side effect.

Researchers are hoping to determine whether the treatment does pose a threat to a patient’s health – and whether this platform can be used in other non-COVID-19 treatments.

“This study has implications for risk management of drug-induced cardiotoxicity, even beyond the current COVID-19 and hydroxychloroquine context,” Professor Jag Singh, a cardiologist at Massachusetts General Hospital, Professor of Medicine at Harvard Medical School and scientific advisor to Cardiologs, said in the press release. “Personal ECG sensors could potentially find a role in the management of these patients, but also add value in other routine clinical care, since over 300 commonly used drugs may have similar QT-prolongation risks as hydroxychloroquine.”

Source: https://mhealthintelligence.com/news/mhealth-study-to-test-cardiac-effects-of-potential-covid-19-treatment

Tags: , , , , ,
Posted in All Recent Posts, CardioComm Solutions | Comments Off on #Mhealth Study to Test Cardiac Effects of Potential COVID-19 Treatment – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

CLIENT FEATURE: Else Nutrition Holdings $BABY.ca An Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:08 PM on Thursday, April 23rd, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Else Nutrition Holdings Inc. | Comments Off on CLIENT FEATURE: Else Nutrition Holdings $BABY.ca An Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Las Vegas Bookmakers Welcoming #Esports Betting – SPONSOR Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 3:49 PM on Thursday, April 23rd, 2020

SPONSOR: Esports Entertainment Group (GMBL:NASDAQ) – Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is the next generation online gambling company designed for the purpose of facilitating as much of this wagering as possible.  LEARN MORE.

Las Vegas Bookmakers Welcoming Esports Betting

  • Regulators have approved wagering on seven further esports events, plus the eNASCAR series that involves real-life pro drivers racing on virtual racetracks
  • Other events approved recently include two League of Legends tournaments and the 2020 Overwatch League

Apr 23, 2020 by Chris Sieroty

Before the coronavirus pandemic, race and sports books in Las Vegas dismissed the notion of posting lines and taking wagers on esports.

Why bet on video game competitions, when you could wager on the Vegas Golden Knights or a long list of NBA games.

But now, searching for an alternative to mainstream sports, the Nevada Gaming Control Board has approved bets on different esports series.

Within the past month, however, regulators have approved wagering on seven further esports events, plus the eNASCAR series that involves real-life pro drivers racing on virtual racetracks.

Other events approved recently include two League of Legends tournaments and the 2020 Overwatch League.

Prior to March 25, the control board had authorized sportsbooks to offer bets on only three major esports tournaments that were held in 2016 and 2017.

It is a regulatory decision William Hill and other bookmakers welcomed, but the new betting opportunities have yet to prove their financial worth compared to betting on the NFL or NBA. 

“Like most new markets, a lot of people don’t know that we have them up,” said Nick Bogdanovich, director of trading for William Hill U.S. â€œIt’s very possible that at some point this stuff will take off, you just never know when.”

Support comes from

Bogdanovich said the tickets have been slow for the esports market, except for the eNASCAR events, but he pointed out that people know the drivers in that event. 

The other events like League of Legends and Overwatch haven’t taken off as much and Bogdanovich admits he doesn’t know much about the video games.

“It’s more for people’s entertainment to get them through this gloom and doom time,” he said, “If it ever gets to where we’re writing serious dollars to it, I might have to sharpen up my acumen.”

Despite Bogdanovich’s skepticism, Blaine Grayboyes, CEO of GameCo, believes esports will be a draw for casinos. 

GameGo creates skill-based games for casinos and has partnered with another company to create an esports data platform. Graboyes said more people watch esports than play them.

“Therefore, the opportunity for more people to bet on esports is there as well,” he said, “What we’re doing is looking to offer the optimal solution in the marketplace for sports books like William Hill and others in Nevada and across North America.”

The new platform will deliver data about esports for sports books.

Graboyes said there is a generational shift going on and the kids who grew up playing video games are now the new customer for casinos.

“This is a great demographic for casinos to engage with now, especially if they want to grow their businesses over time,” he said.

GameCo has created skilled-based games for the casino floor that have the interactivity of video games with the thrill of winning money as the slot machine.

Graboyes said 80 percent of spending on his company’s games come from Gen-X and Millennials, but that same audience only spends about 20 percent on slot machines.

“So, it’s an opportunity to attract and monetize a completely different audience than the traditional slot machine player,” he said.

While Tom Brady and LeBron James are household names, Graboyes said the top gamers are absolutely celebrities to their fans.

Source: https://knpr.org/knpr/2020-04/las-vegas-bookmakers-cautious-welcome-esports-betting

Tags: , , , , , , ,
Posted in All Recent Posts, Esports Entertainment Group, Esports Entertainment Group Inc. | Comments Off on Las Vegas Bookmakers Welcoming #Esports Betting – SPONSOR Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:20 AM on Wednesday, April 22nd, 2020

Empower is utilizing clinics, physicians, technology and direct access to 165,000 patients to launch dedicated division and resources for psilocybin research.

  • Created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder and addiction
  • “Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower

VANCOUVER, BC / April 22, 2020 / EMPOWER CLINICS INC. (CSE: CBDT)(OTC: EPWCF)(Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company is pleased to announce, it is has created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder (PTSD) and addiction.

The Company is leveraging its assets that include the existing clinic network, the developing franchise brand, tele-medicine, access to its 165,000 patients and large physician team, to make advancements in psilocybin research and psychedelics therapy in general.

“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower. “Clinical trials continue to show that psilocybin therapies may provide tremendous help with these conditions, that we see every day in our clinics. As a Company, we must endeavour to utilize our assets and capabilities to positively impact patients’ lives.”

The mental health crisis could cost the world $16 trillion by 2030 according to Future Market Insights and further, the global behavioral health (non-pharmacological) market is expected to be valued at US$156 billion by 2028.

According to the World Health Organization (WHO), depression is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease.

The United States Food and Drug Administration has determined that preliminary clinical evidence indicates psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression; and granted a Breakthrough Therapy designation for a treatment that uses psilocybin as a therapy for such depression.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

NORTHBUD $NBUD.ca – Virtual 4/20: How the #Cannabis Industry Is Adapting Its Signature Holiday for Quarantine $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:30 PM on Monday, April 20th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Virtual 4/20: How the Cannabis Industry Is Adapting Its Signature Holiday for Quarantine

Dispensaries get creative, and celebrities join in, as gatherings give way to livestreams

  • Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion.

  By T.L. Stanley Harvest House of Cannabis  

Many cannabis fans are as devoted to their unofficial holiday, April 20, as some people are to Christmas, Halloween or the Fourth of July. In recent years, as cannabis has grown in mainstream acceptance and legality, 4/20 has been marked with parties and concerts, stadium-sized festivals and pot versions of pub crawls.

But not this year, as the coronavirus response has blocked public gatherings, gutted the experiential industry, canceled nearly every major 4/20 event and substantially altered marketers’ approaches  to the day.

The celebrations will go on, though, as organizers pivot from real-world to virtual gatherings, lining up talent like Wiz Khalifa, Billy Ray Cyrus, Berner and Kid Astronaut for marathon live streams that revelers can watch from the safety of their couches.

Delivery services are prepped for heavy volume in the wake of a record-setting mid-March sales surge, and brands in the space are giving consumers quarantine-friendly ideas to replace their usual in-person meetups and smokeouts. “This is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.” —Steve DeAngelo, co-founder, Harborside dispensary

Dispensaries in states where they’re considered “essential businesses”—and therefore allowed to stay open, while following strict safety protocols and social distancing rules—are leaning into their curbside pickup and contactless delivery options. They’ll be trying to discourage exactly the kinds of crowds at their venues that they’ve actively fostered in the past.

Mainstream, non-cannabis brands that have latched onto the holiday with psychedelic stoner-cliched ads and memes may sit it out all together, similar to this year’s approach to April Fools’ Day, so as not to appear flip or insensitive (or simply wasteful with their resources) during the current pandemic and economic downturn.

All things considered, 4/20 is expected to shed some of the raucous overkill and “amateur night” feel of the recent past in favor of a more thoughtful, subdued vibe.  

“You don’t generally associate 4/20 with restraint,” says Steve DeAngelo, a longtime cannabis activist and co-founder of the Harborside dispensary chain in the Bay Area. “But this is a chance for the cannabis community to model to the rest of the world how holidays should be handled during periods of social crisis.”

Taking no chances, the mayor of San Francisco has publicly warned cannabis devotees not to travel to or gather in the famously open-minded destination, known for its 4/20 meet-ups in places like Golden Gate Park. “We will cite people. We will arrest people if necessary,” London Breed says in an Instagram video. And the Washington State Liquor and Cannabis Board sent out a list of do’s and don’ts to licensed businesses, telling them not to schedule events, hire food trucks or live bands or try in any way to attract large crowds.

Another green rush

Despite all the gloom facing society as 4/20 approaches, it’s predicted to be a massive sales day, contributing to what BDS Analytics thinks will be a 30% jump in retail cannabis sales this year to $17 billion. 

One of the previous high water marks for the industry was April 20, 2019, when recreational cannabis sales increased more than 100%, versus the prior week, in states like California, Colorado, Nevada and Washington, according to cannabis data firm Headset.

“Since 4/20 is on a Monday this year, the sales uptick could start over the weekend or maybe even mid-week,” says Liz Connors, Headset’s director of analytics.

Weedmaps, a national cannabis delivery platform, is girding for a second green rush, following the March spike in sales as stay-at-home mandates were announced. “Conservative estimates could very well put us around eight times the order volume over our baseline, and four to five times what we typically see on this holiday annually,” according to CMO Juanjo Feijoo.

Source: https://www.adweek.com/creativity/virtual-4-20-how-the-cannabis-industry-is-adapting-its-signature-holiday-for-quarantine/

Tags: , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Virtual 4/20: How the #Cannabis Industry Is Adapting Its Signature Holiday for Quarantine $CGC $ACB $APH $CRON.ca $OGI.ca

AGORACOM Welcomes Else Nutrition $BABY.ca – The Award Winning, Plant-Based Nutrition Company For Small Cap Investors; $10,000,000 Cash Balance For US product Launch In Q2 2020, Int’l Agreements Q3

Posted by AGORACOM-JC at 8:30 AM on Monday, April 20th, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

baby-100

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 
nutrition
BABY-screen1

LEARN MORE!

Hub On AGORACOM / Corporate Profile

Tags: , , , , , ,
Posted in AGORACOM Clients (New), All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on AGORACOM Welcomes Else Nutrition $BABY.ca – The Award Winning, Plant-Based Nutrition Company For Small Cap Investors; $10,000,000 Cash Balance For US product Launch In Q2 2020, Int’l Agreements Q3

Else Nutrition $BABY.ca Announces Expansion of Intellectual Property Portfolio to India and Canada

Posted by AGORACOM-JC at 8:24 AM on Monday, April 20th, 2020
  • Announced that the Company has expanded its intellectual property (IP) portfolio to India and Canada
  • Received a formal grant from the Indian Patent office for its patent application 640/CHENP/2015, and a notice of allowance from the Canadian Intellectual Property Office for its patent application 2898980, for its proprietary, clean, plant-based formulation for infant and toddler populations

VANCOUVER, BRITISH COLUMBIA / April 20, 2020 / ELSE NUTRITION HOLDINGS INC. (TSXV:BABY)(OTCQB:BABYF) (“Else” or the “Company“), a developer of novel plant-based infant and toddler nutrition, is pleased to announce that the Company has expanded its intellectual property (IP) portfolio to India and Canada.

The Company has received a formal grant from the Indian Patent office for its patent application 640/CHENP/2015, and a notice of allowance from the Canadian Intellectual Property Office for its patent application 2898980, for its proprietary, clean, plant-based formulation for infant and toddler populations.

“These are highly encouraging developments in key growth markets as we aim to extend our global reach and impact,” stated Ms. Hamutal Yitzhak, Else Nutrition CEO & Co-Founder. She added, “We continue to hear from parents across all geographies that our clean, plant-based infant and toddler formulations can provide a viable alternative for parents seeking an alternative to formulas which contain cow’s milk protein or soy protein.”

Additionally, since March 11, 2020, the Company has engaged AGORACOM for investor awareness, marketing and branding services (the “Advertising Services“). As consideration for the Advertising Services, Else will issue an aggregate of $60,000 plus applicable taxes in the form of common shares of Else (the “Shares“). The Shares are payable in five equal installments during a period from April 2020 until March 2021 for a total term of one-year, as further provided in the online marketing agreement between the Company and AGORACOM. The number of Shares to be issued each time an installment is due will be determined by using the closing price of the Shares of Else on the last trading day following each period for which the Advertising Services were provided. In accordance with Policy 4.3 – Shares for Debt, each Share issuance installment is subject to approval from the TSX Venture Exchange. The number and amount of each issuance will be disclosed by way of a press release when such Shares are issued.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPHGAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition). Plum Organics, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center.

For more information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
Else Nutrition Holdings Inc.
E: [email protected]

Mr. Sokhie Puar, Director of Else Nutrition Holdings Inc.
Telephone: 604-603-7787
Email: [email protected]

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that, to the extent they are not recitations of historical fact, constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “to be”, “intend” or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements with respect to the Company’s expected go-to-market strategy (including marketing, proposed markets, sales, customer growth and market position) and the share issuances made to AGORACOM.

Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct.

Forward-looking statements made in this press release assume, among others, the successful completion of Else’s proposed scale-up for its products, and such statements are intended to apply only to the infant formula market for ages 12 months and above, and having all necessary regulatory approval as required by each target market.

Numerous risks and uncertainties could cause the Company’s actual results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: consumer demand for the Company’s products, whether the Company’s current and future products achieve commercialization, uncertainty regarding material changes in laws and regulations and the Company’s ability to expand into global markets.

In addition, the Company is subject to risks and uncertainties caused by the COVID-19 pandemic which has resulted in governments worldwide enacting emergency measures to combat the spread of the virus including travel bans, self-imposed quarantine periods and social distancing. The outbreak of COVID-19 can impact our operations in a number of ways including quarantined employees, travel restrictions, temporary closure of our office, as well as interruptions to our manufacturing and supply chains.

The foregoing list of factors is not exhaustive, and other risks and uncertainties not presently known, or believed to be material, to management and other factors that could affect the operations or financial results of the Company are set out in the Company’s Filing Statement dated May 14, 2019 under the heading “Risk Factors” and may be accessed through the SEDAR website (www.sedar.com).

Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: ELSE Nutrition Holdings

Tags: , , , , , , ,
Posted in Else Nutrition Holdings Inc. | Comments Off on Else Nutrition $BABY.ca Announces Expansion of Intellectual Property Portfolio to India and Canada

#Esports gambling revenue set to double this year, research finds SPONSOR: Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 3:43 PM on Friday, April 17th, 2020

OUR FEATURED SPONSOR:

GMBL: NASDAQ

WHAT YOU NEED TO KNOW

  • Uplisted to NASDAQ
  • Closed $8.4M public offering
  • Partnered with 190 esports teams
  • Partnered with 250+ esports streamers
  • Launched VIE.gg P2P esports betting platform
  • P2P means an esports fan always wins
  • Superior to “House” model where fans VS. casino
  • Traditional sports teams owners are investing
  • Athletes and celebrities are investing
  • Wall Street is investing
  • Biggest paradigm shift ever seen on the internet

Hub On AGORACOM

————————————–

Esports gambling revenue set to double this year, research finds

30% of current esports gamblers have started within the last month

  • Research from global consumer research agency 2CV and market researcher ProdegeMR has revealed that esports gambling revenue is set to double from $7 billion in 2019 to $14 billion worldwide in 2020 as gamblers seek new alternatives for betting during the sporting events shutdown due to the Covid-19 crisis.

The firms’ survey of 1,028 gamblers aged 18-64 looked at how the pandemic has impacted the gambling climate and the role esports can play in driving revenues for the industry, as reported by SportBusiness.

59% of gamblers have reduced spend on gambling, with 32% having actively looked for new things to bet on and 24% having shifted their focus to other forms of gambling. Also, 69% of respondents said that they had reduced spending on sports gambling, with over half (54%) having stopped spending on sports gambling altogether.

The survey found that 36% of gamblers have bet on esports in the last three months, with 30% of consumers who are betting on esports having only started doing so within the last month. The research also found that 22% of gamblers who have not previously tried betting on esports will consider betting on esports within the next three months, with football, motorsports and tennis proving to be the most popular choices.

62% of respondents said that they needed more information on the sector before gambling on esports. 45% said that esports did not have enough sports-based games, while the same percentage also cited the “assumption that they were more inclined to being fixed” as a reason for avoiding esports betting. Other reasons given for not betting on esports included the assumption that they are less regulated than other sports, that they are two complicated and that it is “too geeky.”

Martin Bradley, research director in technology and entertainment at 2CV, said: “By 2022, the number of esports viewers is estimated to rise to 644 million worldwide, this is up from 454 million viewers in 2019. The Covid-19 pandemic has led to many forms of sports associated with gambling being cancelled or postponed but is also a big opportunity for esports to get in front of this audience.”

“Short-term growth is likely to come from sport-based games, but there are huge opportunities to make this more long-term, as long as consumers are educated properly on esports and what it can offer, as well as considering which kinds of events are best suited to a particular audience,” Bradley concluded.

Source: https://www.yogonet.com/international/noticias/2020/04/17/52967-esports-gambling-revenue-set-to-double-this-year-research-finds

Tags: , , , , , ,
Posted in All Recent Posts | Comments Off on #Esports gambling revenue set to double this year, research finds SPONSOR: Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

« Older Entries
Newer Entries »